Breaking News Instant updates and real-time market news.

BLUE

Bluebird Bio

$76.72 /

-2.79 (-3.51%)

, BMY

Bristol-Myers

$61.32 /

+1.38 (+2.30%)

18:24
12/09/19
12/09
18:24
12/09/19
18:24

Bluebird Bio, Bristol-Myers present update on Phase 1 study of bb21217

Bluebird bio (BLUE) and Bristol-Myers Squibb (BMY) announced updated safety and efficacy results from the ongoing Phase 1 study (CRB-402) of bb21217, an investigational BCMA-targeted chimeric antigen receptor T cell therapy being studied in patients with relapsed/refractory multiple myeloma. The data were presented at the 61st American Society of Hematology Annual Meeting and Exposition in Orlando, Florida. bb21217 is an investigational BCMA-targeted CAR T cell therapy that uses the idecabtagene vicleucel CAR molecule and is cultured with the PI3 kinase inhibitor to enrich for T cells displaying a memory-like phenotype with the intention to increase the in vivo persistence of CAR T cells. "Early data from the CRB-402 study in heavily pre-treated patients (median of six prior lines) with relapsed/refractory multiple myeloma demonstrate the potential for durable responses following bb21217 CAR T cell treatment, with a median duration of response of 11.1 months at the 150 x 106 CAR+ T cell dose level," said David Davidson, M.D., chief medical officer, bluebird bio. "Consistent with the hypothesis underlying the bb21217 program that memory-like phenotype T cells may survive longer in vivo, we have observed durable CAR T cell persistence in evaluable patients with ongoing response at up to 18 months following treatment. We are continuing to recruit additional patients in the study and performing ongoing assessments of the functional persistence of bb21217, as well as its potential correlation to durability of response." "The data of CRB-402 provide additional support that targeting BCMA with a CAR T therapy could be beneficial in treating relapsed/refractory multiple myeloma, particularly for heavily pre-treated patients," said Kristen Hege, M.D., Senior Vice President, Hematology/Oncology and Cell Therapy, Early Clinical Development for Bristol-Myers Squibb. "We have observed durable responses with bb21217 in this study and look forward to further results." "One of the challenges in treating patients with relapsed/refractory multiple myeloma is that they often become resistant to currently available therapies and response durations generally shorten with each subsequent therapy," said presenting author Jesus Berdeja, M.D., Sarah Cannon Center for Blood Cancers, Nashville, Tennessee. "In this heavily-treated patient population, we are encouraged by the results with bb21217 treatment in this ongoing study."

BLUE

Bluebird Bio

$76.72 /

-2.79 (-3.51%)

BMY

Bristol-Myers

$61.32 /

+1.38 (+2.30%)

  • 09

    Dec

  • 11

    Dec

BLUE Bluebird Bio
$76.72 /

-2.79 (-3.51%)

12/08/19 PIPR
Piper says Bluebird's bb2121 'clearly approvable,' but competition heating up
12/09/19 ADAM
Bluebird Bio price target lowered to $118 from $171 at Canaccord
12/09/19 WELS
Bluebird Bio price target lowered to $160 from $242 at Wells Fargo
12/09/19 STFL
Bluebird Bio share rebound potential dampened by JNJ-4528 news, says Stifel
BMY Bristol-Myers
$61.32 /

+1.38 (+2.30%)

11/27/19
Fly Intel: Top analyst initiations
12/03/19 MSCO
Morgan Stanley sees high odds of Bluebird trading up after multiple myeloma data
12/09/19 MZHO
Bristol-Myers Squibb CVR price target raised to $3.99 from $3.14 at Mizuho

TODAY'S FREE FLY STORIES

Periodicals
HP stock 'a good bet,' Barron's says » 14:56
01/25/20
01/25
14:56
01/25/20
14:56
XRX

Xerox

$35.52 /

-0.71 (-1.96%)

, HPQ

HP Inc.

$21.99 /

-0.115 (-0.52%)

For more than two months…

For more than two months now, Xerox (XRX) has been pushing HP Inc. (HPQ) to accept its $32B, $22 a share takeover bid and now it is done asking, with Xerox launching a proxy fight for control of HP and nominating 11 directors to replace the latter's entire board, Eric Savitz writes in this week's edition of Barron's. HP has made it clear that it would prefer to lever up and buy back huge amounts of stock, rather than submit to a Xerox offer that it considers inadequate, but a higher bid could soften HP's position, the author notes. In either scenario, HP investors are likely to benefit, the report adds. Reference Link

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Investors should run away from ad agencies despite Super Bowl, Barron's says » 14:43
01/25/20
01/25
14:43
01/25/20
14:43
BUD

AB InBev

$77.74 /

-0.47 (-0.60%)

, FB

Facebook

$217.89 /

-1.76 (-0.80%)

, OMC

Omnicom

$77.71 /

-1.05 (-1.33%)

, IPG

Interpublic Group

$23.41 /

-0.13 (-0.55%)

, PUBGY

Publicis

$0.00 /

+ (+0.00%)

, WPP

WPP

$65.07 /

-0.81 (-1.23%)

, GOOG

Alphabet

$1,466.47 /

-19.67 (-1.32%)

, GOOGL

Alphabet Class A

$1,465.80 /

-19.06 (-1.28%)

, ACN

Accenture

$208.56 /

-2.16 (-1.03%)

, IBM

IBM

$140.54 /

-2.36 (-1.65%)

, CRM

Salesforce

$182.11 /

-1.89 (-1.03%)

, ORCL

Oracle

$54.07 /

-0.91 (-1.66%)

Super Bowl commercials…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Big techs competing for bigger slice of esports business, Barron's says » 14:35
01/25/20
01/25
14:35
01/25/20
14:35
ATVI

Activision Blizzard

$59.36 /

-0.77 (-1.28%)

, GOOGL

Alphabet Class A

$1,465.80 /

-19.06 (-1.28%)

, GOOG

Alphabet

$1,466.47 /

-19.67 (-1.32%)

, MSFT

Microsoft

$165.03 /

-1.69 (-1.01%)

, AMZN

Amazon.com

$1,862.09 /

-22.76 (-1.21%)

Big tech companies,…

Big tech companies, including Amazon (AMZN), Microsoft (MSFT), and Alphabet (GOOGL), are competing for a bigger slice of the esports live-streaming business, which could present an opportunity for investors, Connor Smith writes in this week's edition of Barron's. Esports events - where the best players compete in games like League of Legends, Activision Blizzard's (ATVI) Overwatch, and Valve's Dota 2 and Counter-Strike: Global Offensive - are attracting young people, much the way traditional sports had for generations, the author notes. Reference Link

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Investors can buy into sports teams, valuation lofty, Barron's says » 14:28
01/25/20
01/25
14:28
01/25/20
14:28
MSG

Madison Square Garden

$296.18 /

-0.47 (-0.16%)

, MANU

Manchester United

$18.97 /

-0.04 (-0.21%)

, BATRK

Liberty Braves

$29.15 /

-0.13 (-0.44%)

Investors can buy shares…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Sports gambling will be 'huge opportunity,' Barron's says » 08:37
01/25/20
01/25
08:37
01/25/20
08:37
DEAC

Diamond Eagle Acquisition

$14.39 /

-0.03 (-0.21%)

, PDYPY

Flutter Entertainment

$0.00 /

+ (+0.00%)

Super Bowl is the biggest…

Super Bowl is the biggest day of the year for sports gambling and this year an increasing share of the wagering on the February 2 game between the San Francisco 49ers and the Kansas City Chiefs will be done legally, Andrew Bary writes in this week's edition of Barron's. Sports betting has quickly become the hottest trend in the U.S. gambling industry, with the latter focusing its expansion on mobile sports gambling, rather than the sports books patterned on those at Las Vegas casinos, the author notes. The Street's enthusiasm is most evident in the surging stock price of Diamond Eagle Acquisition (DEAC), a special purpose acquisition company, or SPAC, that reached a deal in late December to buy DraftKings, the report adds. The other chief play on U.S. sports gambling is Flutter Entertainment (PDYPY), the top U.K. betting company that controls FanDuel, the main online U.S. sports wagering rival for DraftKings. Reference Link

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

On The Fly
Week in Review: How Trump's policies moved stocks » 08:12
01/25/20
01/25
08:12
01/25/20
08:12
GOOG

Alphabet

$1,466.47 /

-19.67 (-1.32%)

, GOOGL

Alphabet Class A

$1,465.80 /

-19.06 (-1.28%)

, AAPL

Apple

$318.25 /

-1.02 (-0.32%)

, FB

Facebook

$217.89 /

-1.76 (-0.80%)

, AMZN

Amazon.com

$1,862.09 /

-22.76 (-1.21%)

, MSFT

Microsoft

$165.03 /

-1.69 (-1.01%)

, CNC

Centene

$66.58 /

-1.5 (-2.20%)

, UNH

UnitedHealth

$292.89 /

-6.51 (-2.17%)

, CVS

CVS Health

$71.44 /

-2.08 (-2.83%)

, CI

Cigna

$206.12 /

-6.59 (-3.10%)

, SIEGY

Siemens

$0.00 /

+ (+0.00%)

Catch up on the top…

Open Full Text

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
American Society of Clinical Oncology to hold a symposium » 04:55
01/25/20
01/25
04:55
01/25/20
04:55
AMZN

Amazon.com

$1,862.09 /

-22.76 (-1.21%)

, AGIO

Agios Pharmaceuticals

$53.04 /

-0.22 (-0.41%)

, AZN

AstraZeneca

$49.28 /

-0.93 (-1.85%)

, BAYRY

Bayer

$0.00 /

+ (+0.00%)

, BMY

Bristol-Myers

$64.18 /

-2.715 (-4.06%)

, CELG

Bought by BMY

$0.00 /

+ (+0.00%)

, DNA

Bought by RHHBY

$0.00 /

+ (+0.00%)

, DSNKY

Daiichi Sankyo

$0.00 /

+ (+0.00%)

, ERYP

Erytech Pharma

$7.10 /

+ (+0.00%)

, ESALY

Eisai

$0.00 /

+ (+0.00%)

, EXEL

Exelixis

$18.01 /

-1.57 (-8.02%)

, FGEN

FibroGen

$41.80 /

-2.35 (-5.32%)

, HSDEF

Harborside

$0.00 /

+ (+0.00%)

, INCY

Incyte

$76.66 /

-1.56 (-1.99%)

, LXRX

Lexicon

$3.37 /

-0.07 (-2.03%)

, MRK

Merck

$85.96 /

-2.56 (-2.89%)

, NTRA

Natera

$35.71 /

-1.08 (-2.94%)

, NVTA

Invitae

$18.35 /

-0.15 (-0.81%)

, PFE

Pfizer

$39.82 /

-0.89 (-2.19%)

, PGNX

Progenics

$4.65 /

-0.045 (-0.96%)

, SGEN

Seattle Genetics

$113.63 /

-1.69 (-1.47%)

, TROV

Trovagene

$1.69 /

-0.075 (-4.25%)

2020 Gastrointestinal…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Naitonal Marine Manufacturers Association to hold ashow » 04:55
01/25/20
01/25
04:55
01/25/20
04:55

New York Boat Show will…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Conference/Events
Crohn's & Colitis Foundation to hold a conference » 04:55
01/25/20
01/25
04:55
01/25/20
04:55
ABBV

AbbVie

$83.53 /

-1.73 (-2.03%)

, ARNA

Arena Pharmaceuticals

$44.54 /

-1.27 (-2.77%)

, BMY

Bristol-Myers

$64.18 /

-2.715 (-4.06%)

, CELG

Bought by BMY

$0.00 /

+ (+0.00%)

, DNA

Bought by RHHBY

$0.00 /

+ (+0.00%)

, GILD

Gilead

$63.12 /

-0.84 (-1.31%)

, LLY

Eli Lilly

$139.09 /

-2.14 (-1.52%)

, PFE

Pfizer

$39.82 /

-0.89 (-2.19%)

, TAK

Takeda Pharmaceutical

$19.84 /

-0.185 (-0.92%)

, UCBJF

UCB

$0.00 /

+ (+0.00%)

, UCBJY

UCB

$0.00 /

+ (+0.00%)

2020 Crohn's &…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Babcock & Wilcox says continues to work toward refinancing debt » 18:33
01/24/20
01/24
18:33
01/24/20
18:33
BW

Babcock & Wilcox

$4.55 /

+ (+0.00%)

Babcock & Wilcox…

Babcock & Wilcox announced that the company continues to work toward refinancing its current senior debt and extending its maturity and, as a result, has entered into an Amendment to further extend the deadline for completing certain required corporate actions in connection with the refinancing of its existing Credit Agreement. The deadline to complete these actions has been extended from January 20 to January 31. As previously disclosed, the company is required to refinance by March 15. "We are continuing to work closely with our existing lenders to reach an agreement that will provide long-term restructuring of our debt," said Kenneth Young, B&W CEO. "We expect to make a further announcement regarding the agreement on or before January 31, 2020."

General news
Weekly CFTC Commitment of Traders highlights » 17:56
01/24/20
01/24
17:56
01/24/20
17:56
IEF

iShares 7-10 Year Treasury Bond ETF

$112.45 /

+0.395 (+0.35%)

, SHY

iShares 1-3 Year Treasury Bond

$84.88 /

+0.035 (+0.04%)

, SPY

SPDR S&P 500 ETF Trust

$328.73 /

-2.99 (-0.90%)

, SLV

iShares Silver Trust

$16.91 /

+0.29 (+1.74%)

, GLD

SPDR Gold Shares

$147.96 /

+0.85 (+0.58%)

, FXE

Euro Currency Trust

$104.46 /

-0.28 (-0.27%)

2-YEAR U.S. TREASURY net…

2-YEAR U.S. TREASURY net short 321.4K contracts, up 39.7K from prior week... 10-YEAR U.S. TREASURY net short 302.5K contracts, up 79.0K from prior week and a 4-month high in net shorts... 30-DAY FED FUNDS FUTURES net long 355.9K contracts, down 41.1K from prior week and a 3-week low in net longs... CONSOLIDATED S&P 500 FUTURES net long 4.6K contracts, down 3.9K from prior week and a 5-week low in net longs... E-MINI RUSSELL FUTURES net long 54.3K contracts, up 5.6K from prior week and an 18-month high in net longs... U.S. DOLLAR INDEX net long 12.9K contracts, down 0.3K from prior week... EURO net short 47.0K contracts, down 1.2K from prior week and a 5-month low in net shorts... BRITISH POUND net long 24.9K contracts, down 6.6K from prior week... JAPANESE YEN net short 44.7K contracts, up 13.3K from prior week and a 7-week high in net shorts... SWISS FRANC net long 1.5K contracts, first net long position since December 2016... AUSTRALIAN DOLLAR net short 19.3K contracts, down 1.2K from prior week and a 19-month low in net shorts... NEW ZEALAND DOLLAR net long 1.8K contracts, first net long position since March 2019... CANADIAN DOLLAR net long 38.3K contracts, up 5.4K from prior week and a 2-month high in net longs... MEXICAN PESO net long 167.0K contracts, up 4.3K from prior week and a multi-year high in net longs... CRUDE OIL net long 520.6K contracts, down 9.7K from prior week and a 6-week low in net longs... GOLD net long 317.7K contracts, down 1.5K from prior week and a 4-week low in net longs... SILVER net long 68.9K contracts, up 1.5K from prior week and a 3-week high in net longs... COPPER net long 5.8K contracts, up 2.3K from prior week and a 19-month high in net longs.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Consolidated-Tomoka acquires retail center in AZ for $61.8M » 17:54
01/24/20
01/24
17:54
01/24/20
17:54
CTO

Consolidated-Tomoka

$64.50 /

+0.05 (+0.08%)

Consolidated-Tomoka…

Consolidated-Tomoka announced the purchase of Crossroads Towne Center, an approximately 25K square foot retail center in Chandler, Arizona, for $61.8M, representing a going-in cap rate of approximately 7.85%. The weighted average lease term for the leases of all 32 tenants at Crossroads is approximately 5 years.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
9 state AGs urge judge to dismiss Google's 'Wi-Spy' settlement, Bloomberg says » 17:44
01/24/20
01/24
17:44
01/24/20
17:44
GOOG

Alphabet

$1,466.47 /

-19.67 (-1.32%)

, GOOGL

Alphabet Class A

$1,465.80 /

-19.06 (-1.28%)

Attorneys general from…

Attorneys general from nine U.S. states are urging a federal judge to dismiss Google's $13M settlement of a class-action lawsuit claiming that its Street View mapping technology violated consumer privacy, Bloomberg's Malathi Nayak reports. The proposed settlement in a matter that became known as "Wi-Spy" does not offer compensation for millions of people whose confidential information was captured off their Wi-FI networks by Street View vehicles, and instead the accord divvies up funds among a handful of privacy rights organizations, a small number of individual consumers who led the case, and their attorneys, Nayak says, citing the state officials in a court filing. "Without receiving any of the $13 million cash fund or any meaningful injunctive relief, class members receive no direct benefit from the settlement," the attorneys general said. Reference Link

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
PG&E probation judge threatens to restrict pay bonuses, Bloomberg says » 17:40
01/24/20
01/24
17:40
01/24/20
17:40
PCG

PG&E

$14.27 /

+0.51 (+3.71%)

PG&E Corp. (PCG)…

PG&E Corp. (PCG) could be ordered by probation judge William Alsup to "restrict bonuses and incentives for supervisors and other high-ranking employees until the company meets its obligations under its wildfire-prevention plan," according to Bloomberg's Peter Blumberg and Mark Chediak. The judge additionally threatened to tie incentive pay to the company meeting its fire mitigation and safety goals. The judge has asked PG&E to explain why he shouldn't issue such an order, the report added. Reference Link

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Four Corners Property Trust acquires recreational equipment property for $5.2M » 17:40
01/24/20
01/24
17:40
01/24/20
17:40
FCPT

Four Corners Property Trust

$29.72 /

+0.275 (+0.93%)

, PEI

Pennsylvania REIT

$4.50 /

-0.37 (-7.60%)

Four Corners Property…

Four Corners Property Trust (FCPT) announced the acquisition of a recreational equipment property for $5.2M as part of a previously announced outparcel transaction with Pennsylvania REIT (PEI). The property is located in Michigan and is occupied under a net lease with nine years of term remaining. The property is newly constructed and is leased to the corporate operator. This transaction is the second closing of the previously announced PREIT portfolio transaction in November, priced at a 6.5% going-in cash cap rate, on a portfolio basis, exclusive of transaction costs.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Syndicate
H.B. Fuller files automatic mixed securities shelf  17:33
01/24/20
01/24
17:33
01/24/20
17:33
FUL

H.B. Fuller

$48.35 /

-0.69 (-1.41%)

 
ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Syndicate
Suzano files automatic mixed securities shelf  17:26
01/24/20
01/24
17:26
01/24/20
17:26
SUZ

Suzano

$10.38 /

-0.28 (-2.63%)

 
ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Syndicate
Document Security files to sell $6M in common stock » 17:22
01/24/20
01/24
17:22
01/24/20
17:22
DSS

Document Security

$0.30 /

-0.0225 (-6.98%)

Aegis Capital acted as…

Aegis Capital acted as sole book running manager for the offering.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Syndicate
New Frontier Health files to sell 127.34M ordinary shares for holders » 17:10
01/24/20
01/24
17:10
01/24/20
17:10
NFH

New Frontier Health

$9.45 /

+0.105 (+1.12%)

Also files to sell 12.5M…

Also files to sell 12.5M warrants for holders.

Syndicate
New Frontier Health files to sell 26.875M ordinary shares  17:09
01/24/20
01/24
17:09
01/24/20
17:09
NFH

New Frontier Health

$9.45 /

+0.105 (+1.12%)

 
Syndicate
Willamette Valley Vineyards files $20M mixed securities shelf  17:08
01/24/20
01/24
17:08
01/24/20
17:08
WVVI

Willamette Valley Vineyards

$6.75 /

-0.14 (-2.03%)

 
Hot Stocks
Ashland appoints Dr. Xiaolan Wang to lead Personal Care business unit » 17:04
01/24/20
01/24
17:04
01/24/20
17:04
ASH

Ashland

$75.33 /

-0.66 (-0.87%)

Ashland announced Dr.…

Ashland announced Dr. Xiaolan Wang will be joining the company to lead the Personal Care business unit, effective February 1. Wang will report directly to CEO Guillermo Novo. Most recently Wang had global P&L responsibility for a diverse specialty additive business at Evonik. Previously, she held leadership roles at Dow, Rohm & Haas, and ICI.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
eHealth CEO sells 121K shares of common stock » 16:59
01/24/20
01/24
16:59
01/24/20
16:59
EHTH

eHealth

$123.20 /

+26.11 (+26.89%)

In a regulatory filing,…

In a regulatory filing, eHealth disclosed that its CEO Scott Flanders sold 121K shares of common stock on January 22nd-24th. The total transaction size was about $13.3M.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Syndicate
Can-Fite BioPharma files to sell $5M of units  16:43
01/24/20
01/24
16:43
01/24/20
16:43
CANF

Can-Fite BioPharma

$2.71 /

+0.02 (+0.74%)

 
ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
F5 Networks completes acquisition of Shape Security » 16:35
01/24/20
01/24
16:35
01/24/20
16:35
FFIV

F5 Networks

$135.83 /

+1.92 (+1.43%)

F5 Networks announced…

F5 Networks announced that it has completed the acquisition of Shape Security, a leader in online fraud and abuse prevention, adding protection from automated attacks, botnets, and targeted fraud to F5's world-class portfolio of application services. On December 19, 2019, F5 announced that it had entered into an agreement to acquire Shape. F5 said "this acquisition delivers superior value to customers by combining F5 and NGINX's expertise in powering over half of the world's applications across all types of environments, with Shape's insight from mitigating 1B application attacks per day through sophisticated AI, cloud-based analytics, and anti-fraud technologies."

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.